{"entity":{"type":"insider","cik":"0001506314","url":"/insider/0001506314","json_url":"/insider/0001506314.json","name":"Kelly James Patrick","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":12,"first":"2011-08-30","last":"2020-03-04","span_basis":"filed_date"},"name_variants":[{"name":"Kelly James Patrick","source":"filing","n_filings":12,"first_seen":"2011-08-30","last_seen":"2020-03-04"}],"transactions":[{"id":2334635,"accession":"0001209191-20-016200","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-016200","line_url":"/filing/0001209191-20-016200#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001506314","owner_name":"Kelly James Patrick","owner_display_name":"Kelly James Patrick","owner_url":"/insider/0001506314","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5889.0,"shares_display":"5,889","price_per_share":10.7589,"price_display":"10.76","price_state":"stated","total_value":63359.1621,"total_display":"63,359.16","total_whole":"63,359","shares_owned_after":186869.0,"shares_owned_after_display":"186,869","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-03","filed_date":"2020-03-04","scope":"insider"},{"id":2334627,"accession":"0001209191-20-016200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-016200","line_url":"/filing/0001209191-20-016200#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001506314","owner_name":"Kelly James Patrick","owner_display_name":"Kelly James Patrick","owner_url":"/insider/0001506314","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12968.0,"shares_display":"12,968","price_per_share":10.1856,"price_display":"10.19","price_state":"stated","total_value":132086.8608,"total_display":"132,086.86","total_whole":"132,087","shares_owned_after":192758.0,"shares_owned_after_display":"192,758","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-04","scope":"insider"},{"id":2528592,"accession":"0001209191-20-002029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-002029","line_url":"/filing/0001209191-20-002029#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001506314","owner_name":"Kelly James Patrick","owner_display_name":"Kelly James Patrick","owner_url":"/insider/0001506314","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4020.0,"shares_display":"4,020","price_per_share":15.9418,"price_display":"15.94","price_state":"stated","total_value":64086.036,"total_display":"64,086.04","total_whole":"64,086","shares_owned_after":205726.0,"shares_owned_after_display":"205,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-06","scope":"insider"},{"id":7921465,"accession":"0001209191-19-015737","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-015737","line_url":"/filing/0001209191-19-015737#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001506314","owner_name":"Kelly James Patrick","owner_display_name":"Kelly James Patrick","owner_url":"/insider/0001506314","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8751.0,"shares_display":"8,751","price_per_share":19.879,"price_display":"19.88","price_state":"stated","total_value":173961.129,"total_display":"173,961.13","total_whole":"173,961","shares_owned_after":209746.0,"shares_owned_after_display":"209,746","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-04","filed_date":"2019-03-04","scope":"insider"},{"id":7921461,"accession":"0001209191-19-015737","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-015737","line_url":"/filing/0001209191-19-015737#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001506314","owner_name":"Kelly James Patrick","owner_display_name":"Kelly James Patrick","owner_url":"/insider/0001506314","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4976.0,"shares_display":"4,976","price_per_share":20.151,"price_display":"20.15","price_state":"stated","total_value":100271.376,"total_display":"100,271.38","total_whole":"100,271","shares_owned_after":218497.0,"shares_owned_after_display":"218,497","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-01","filed_date":"2019-03-04","scope":"insider"},{"id":8411115,"accession":"0001209191-19-001986","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-001986","line_url":"/filing/0001209191-19-001986#line-3","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001506314","owner_name":"Kelly James Patrick","owner_display_name":"Kelly James Patrick","owner_url":"/insider/0001506314","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1619.0,"shares_display":"1,619","price_per_share":26.085,"price_display":"26.08","price_state":"stated","total_value":42231.615,"total_display":"42,231.62","total_whole":"42,232","shares_owned_after":193473.0,"shares_owned_after_display":"193,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-03","filed_date":"2019-01-04","scope":"insider"},{"id":8411112,"accession":"0001209191-19-001986","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-001986","line_url":"/filing/0001209191-19-001986","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001506314","owner_name":"Kelly James Patrick","owner_display_name":"Kelly James Patrick","owner_url":"/insider/0001506314","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4442.0,"shares_display":"4,442","price_per_share":26.46986965330932,"price_display":"26.47","price_state":"stated","total_value":117579.161,"total_display":"117,579.16","total_whole":"117,579","shares_owned_after":196221.0,"shares_owned_after_display":"196,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-01-04","scope":"insider","n_lines":2},{"id":6393801,"accession":"0001209191-18-015882","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-015882","line_url":"/filing/0001209191-18-015882#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001506314","owner_name":"Kelly James Patrick","owner_display_name":"Kelly James Patrick","owner_url":"/insider/0001506314","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8532.0,"shares_display":"8,532","price_per_share":18.7192,"price_display":"18.72","price_state":"stated","total_value":159712.2144,"total_display":"159,712.21","total_whole":"159,712","shares_owned_after":199534.0,"shares_owned_after_display":"199,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-01","filed_date":"2018-03-02","scope":"insider"},{"id":6630697,"accession":"0001209191-18-002060","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-18-002060","line_url":"/filing/0001209191-18-002060#line-4","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001506314","owner_name":"Kelly James Patrick","owner_display_name":"Kelly James Patrick","owner_url":"/insider/0001506314","role":"Officer (EVP & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (EVP & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9155.0,"shares_display":"9,155","price_per_share":15.3461,"price_display":"15.35","price_state":"stated","total_value":140493.5455,"total_display":"140,493.55","total_whole":"140,494","shares_owned_after":168066.0,"shares_owned_after_display":"168,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider"},{"id":5059212,"accession":"0001209191-17-002200","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-002200","line_url":"/filing/0001209191-17-002200#line-5","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001506314","owner_name":"Kelly James Patrick","owner_display_name":"Kelly James Patrick","owner_url":"/insider/0001506314","role":"Officer (SVP, CFO & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10895.0,"shares_display":"10,895","price_per_share":15.5129,"price_display":"15.51","price_state":"stated","total_value":169013.0455,"total_display":"169,013.05","total_whole":"169,013","shares_owned_after":69721.0,"shares_owned_after_display":"69,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-03","filed_date":"2017-01-05","scope":"insider"},{"id":3029875,"accession":"0001209191-16-090125","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-090125","line_url":"/filing/0001209191-16-090125#line-5","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001506314","owner_name":"Kelly James Patrick","owner_display_name":"Kelly James Patrick","owner_url":"/insider/0001506314","role":"Officer (SVP, CFO, Sec & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO, Sec & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO, Sec & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9564.0,"shares_display":"9,564","price_per_share":8.96,"price_display":"8.96","price_state":"stated","total_value":85693.44,"total_display":"85,693.44","total_whole":"85,693","shares_owned_after":60772.0,"shares_owned_after_display":"60,772","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-06","scope":"insider"},{"id":8458849,"accession":"0001209191-15-025770","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-025770","line_url":"/filing/0001209191-15-025770#line-5","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001506314","owner_name":"Kelly James Patrick","owner_display_name":"Kelly James Patrick","owner_url":"/insider/0001506314","role":"Officer (SVP, CFO, Sec & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO, Sec & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO, Sec & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12450.0,"shares_display":"12,450","price_per_share":10.53,"price_display":"10.53","price_state":"stated","total_value":131098.5,"total_display":"131,098.50","total_whole":"131,099","shares_owned_after":53304.0,"shares_owned_after_display":"53,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-10","filed_date":"2015-03-12","scope":"insider"},{"id":4307005,"accession":"0001209191-13-053647","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-053647","line_url":"/filing/0001209191-13-053647#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001506314","owner_name":"Kelly James Patrick","owner_display_name":"Kelly James Patrick","owner_url":"/insider/0001506314","role":"Officer (SVP, CFO, Sec & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO, Sec & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO, Sec & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3348.0,"shares_display":"3,348","price_per_share":12.0731,"price_display":"12.07","price_state":"stated","total_value":40420.7388,"total_display":"40,420.74","total_whole":"40,421","shares_owned_after":28816.0,"shares_owned_after_display":"28,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-19","filed_date":"2013-11-21","scope":"insider"},{"id":3173082,"accession":"0001209191-12-011830","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-011830","line_url":"/filing/0001209191-12-011830#line-2","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001506314","owner_name":"Kelly James Patrick","owner_display_name":"Kelly James Patrick","owner_url":"/insider/0001506314","role":"Officer (SVP, CFO, Sec & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO, Sec & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO, Sec & Treasurer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4920.0,"shares_display":"4,920","price_per_share":4.6736,"price_display":"4.67","price_state":"stated","total_value":22994.112,"total_display":"22,994.11","total_whole":"22,994","shares_owned_after":12580.0,"shares_owned_after_display":"12,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-16","filed_date":"2012-02-21","scope":"insider"},{"id":9144063,"accession":"0001209191-11-046001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-046001","line_url":"/filing/0001209191-11-046001#line-1","is_derivative":false,"issuer_cik":"0001347178","issuer_name":"Vanda Pharmaceuticals Inc.","issuer_ticker":"VNDA","issuer_name_source":null,"issuer_url":"/issuer/0001347178","owner_cik":"0001506314","owner_name":"Kelly James Patrick","owner_display_name":"Kelly James Patrick","owner_url":"/insider/0001506314","role":"Officer (SVP, CFO, Sec & Treasurer)","role_mark":"O","role_mark_label":"Officer (SVP, CFO, Sec & Treasurer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, CFO, Sec & Treasurer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.9904,"price_display":"5.99","price_state":"stated","total_value":29952.0,"total_display":"29,952.00","total_whole":"29,952","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-29","filed_date":"2011-08-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001347178","name":"Vanda Pharmaceuticals Inc.","url":"/issuer/0001347178","role":"Officer (EVP & Chief Financial Officer)","n_filings":12,"first_seen":"2011-08-30","last_seen":"2020-03-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001506314","retrieved_at":"2026-08-24T13:15:26+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}